US Bancorp
DNA icon

US Bancorp’s Ginkgo Bioworks DNA Stock Holding History

US Bancorp’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.4K Buy
4,684
+51
+1% +$426 ﹤0.01% 2832
2026
Q1 		$28.4K Sell
4,633
-2,173
-32% -$18.1K ﹤0.01% 2947
2025
Q4 		$56.6K Buy
6,806
+444
+7% +$4.78K ﹤0.01% 2641
2025
Q3 		$92.8K Buy
6,362
+370
+6% +$4.43K ﹤0.01% 2386
2025
Q2 		$67.4K Sell
5,992
-310
-5% -$2.4K ﹤0.01% 2637
2025
Q1 		$35.9K Buy
6,302
+1,911
+44% +$19.5K ﹤0.01% 2903
2024
Q4 		$43.1K Buy
4,391
+55
+1% +$471 ﹤0.01% 2811
2024
Q3 		$35.3K Sell
4,336
-359
-8% -$3.6K ﹤0.01% 2902
2024
Q2 		$62.8K Sell
4,695
-2,925
-38% -$87.3K ﹤0.01% 2547
2024
Q1 		$354K Sell
7,620
-449
-6% -$23.2K ﹤0.01% 1705
2023
Q4 		$545K Buy
8,069
+3,198
+66% +$196K ﹤0.01% 1435
2023
Q3 		$353K Buy
4,871
+91
+2% +$7.28K ﹤0.01% 1550
2023
Q2 		$356K Sell
4,780
-2,378
-33% -$141K ﹤0.01% 1578
2023
Q1 		$381K Buy
7,158
+11
+0.2% +$697 ﹤0.01% 1546
2022
Q4 		$483K Sell
7,147
-1,810
-20% -$166K ﹤0.01% 1415
2022
Q3 		$1.12M Sell
8,957
-2,372
-21% -$283K ﹤0.01% 1009
2022
Q2 		$1.08M Buy
11,329
+5,093
+82% +$621K ﹤0.01% 1062
2022
Q1 		$1M Buy
+6,236
New +$1.21M ﹤0.01% 1187
2021
Q4 		– Sell
-200
Closed -$93K – 4124
2021
Q3 		$93K Buy
+200
New +$97.4K ﹤0.01% 2338

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

US Bancorp's DNA Position: Q2 2026 in Review

US Bancorp increased its Ginkgo Bioworks (DNA) stake by 1.1% in Q2 2026, buying an estimated $426 and bringing the position to 4,684 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2832.

US Bancorp first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.12M in Q3 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • US Bancorp held 4,684 shares of Ginkgo Bioworks worth $46.4K as of Q2 2026.
  • US Bancorp bought 51 Ginkgo Bioworks shares in Q2 2026, an estimated $426.
  • Ginkgo Bioworks made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2832 holding.
  • US Bancorp first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • US Bancorp's Ginkgo Bioworks position peaked at $1.12M in Q3 2022.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.